Literature DB >> 22733476

True mixed medullary papillary carcinoma of the thyroid: a case report with low blood calcitonin levels.

Pablo Zoroquiain1, Javiera Torres, Ignacio Goñi, Lizzet Fernández, Antonieta Solar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22733476     DOI: 10.1007/s12022-012-9217-8

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


× No keyword cloud information.
  10 in total

1.  Mixed medullary and follicular carcinoma of the thyroid. On the search for its histogenesis.

Authors:  X Matias-Guiu
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma.

Authors:  M M Walther; R Reiter; H R Keiser; P L Choyke; D Venzon; K Hurley; J R Gnarra; J C Reynolds; G M Glenn; B Zbar; W M Linehan
Journal:  J Urol       Date:  1999-09       Impact factor: 7.450

3.  Mixed medullary-papillary carcinoma of the thyroid: a previously unrecognized variant of thyroid carcinoma.

Authors:  J Albores-Saavedra; T Gorraez de la Mora; F de la Torre-Rendon; E Gould
Journal:  Hum Pathol       Date:  1990-11       Impact factor: 3.466

4.  Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components.

Authors:  M Volante; M Papotti; J Roth; P Saremaslani; E J Speel; R V Lloyd; J A Carney; P U Heitz; G Bussolati; P Komminoth
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses.

Authors:  A H Redding; S N Levine; M R Fowler
Journal:  Thyroid       Date:  2000-10       Impact factor: 6.568

6.  Mixed medullary-follicular carcinoma of the thyroid: diagnostic dilemmas in fine-needle aspiration cytology.

Authors:  Atef N Hanna; Claire W Michael; Xin Jing
Journal:  Diagn Cytopathol       Date:  2010-12-03       Impact factor: 1.582

7.  Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma.

Authors:  Daisy V Alapat; Kenneth B Ain; David A Sloan; Kristin G Monaghan; Rouzan G Karabakhtsian
Journal:  Endocrine       Date:  2011-01-18       Impact factor: 3.633

8.  Carcinoma of the thyroid with a mixed medullary, papillary, follicular, and undifferentiated pattern.

Authors:  L N Parker; J Kollin; S Y Wu; E B Rypins; G L Juler
Journal:  Arch Intern Med       Date:  1985-08

9.  Coexistence of papillary and medullary carcinoma of the thyroid gland-mixed or collision tumour? Clinicopathological analysis of three cases.

Authors:  S F Lax; A Beham; D Kronberger-Schönecker; W Langsteger; H Denk
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Relevance of immunocytochemistry on thin-layer cytology in thyroid lesions suspicious for medullary carcinoma: a case-control study.

Authors:  Esther Diana Rossi; Marco Raffaelli; Antonino Mulè; Gian Franco Zannoni; Alfredo Pontecorvi; Giuseppe Santeusanio; Corrado Minimo; Guido Fadda
Journal:  Appl Immunohistochem Mol Morphol       Date:  2008-12
  10 in total
  3 in total

1.  F-18 FDG-PET-CT in the Diagnostic of a Late Medullary Thyroid Carcinoma Recurrence in a Patient with Follicular-Papillary Thyroid Cancer.

Authors:  Doina Piciu; Andra Piciu
Journal:  Case Rep Endocrinol       Date:  2014-02-20

2.  Mixed subtype thyroid cancer: A surveillance, epidemiology, and end results database analysis.

Authors:  Chunping Liu; Qiuyang Zhao; Zhi Li; Shuntao Wang; Yiquan Xiong; Zeming Liu; Tao Huang
Journal:  Oncotarget       Date:  2017-09-23

Review 3.  Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers.

Authors:  José Manuel Cameselle-Teijeiro; Catarina Eloy; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2020-07-06       Impact factor: 3.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.